School-age outcomes following a randomized controlled trial of magnesium sulfate for neuroprotection of preterm infants.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 24837863.
- Also identified by DOI 10.1016/j.jpeds.2014.04.007.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In a French randomized trial, children at school-age demonstrated no evidence of harm from fetal exposure to MgSO4 before very preterm birth. Motor dysfunction/death, qualitative behavioral disorders, cognitive difficulties, school grade repetition, and education services were decreased in the children exposed to MgSO4, although the differences were not significant.
Medical subject headings
- Cerebral Palsy
- Infant, Premature, Diseases
- Magnesium Sulfate
- Neuroprotective Agents
- Prenatal Exposure Delayed Effects